Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Toth

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2005
Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromesJulia I Toth, Shao H Yang, Xin Qiao, et al.
EMBO Reports|June 27, 2009
REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A-DDB1 ubiquitin ligaseSamiksha Katiyar, Enbo Liu, Christine A Knutzen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2005
Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutationShao H Yang, Martin O Bergo, Julia I Toth, et al.
The Journal of Investigative Dermatology|October 17, 2013
PPARγ-mediated and arachidonic acid-dependent signaling is involved in differentiation and lipid production of human sebocytesAniko Dozsa, Balazs Dezso, Balazs I Toth, et al.
Epidemiology and Infection|July 23, 2013
Use of virulence determinants and seropathotypes to distinguish high- and low-risk Escherichia coli O157 and non-O157 isolates from EuropeM F Anjum, E Jones, V Morrison, et al.
Molecular Cancer Therapeutics|July 5, 2024
Discovery of Monovalent Direct Degraders of BRD4 that Act via the Recruitment of DCAF11Gregory S Parker, Julia I Toth, Sarah Fish, et al.
Molecular Cancer Therapeutics|June 22, 2024
Discovery of Monovalent Direct Degraders of BRD4 That Act Via the Recruitment of DCAF11Gregory S Parker, Julia I Toth, Sarah Fish, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery and Structural Optimization of BRD4-Selective Monovalent Direct DegradersGeoffray Leriche, Farhana Barmare, Julia I Toth, et al.
Plos One|April 3, 2014
Mutations in UBA3 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cellsG Wei Xu, Julia I Toth, Sara R da Silva, et al.
Science (New York, N.Y.)|May 19, 2001
HST and VLT investigations of the fragments of comet C/1999 S4 (LINEAR)H A Weaver, Z Sekanina, I Toth, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2005
Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromesJulia I Toth, Shao H Yang, Xin Qiao, et al.
EMBO Reports|June 27, 2009
REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A-DDB1 ubiquitin ligaseSamiksha Katiyar, Enbo Liu, Christine A Knutzen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2005
Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutationShao H Yang, Martin O Bergo, Julia I Toth, et al.
The Journal of Investigative Dermatology|October 17, 2013
PPARγ-mediated and arachidonic acid-dependent signaling is involved in differentiation and lipid production of human sebocytesAniko Dozsa, Balazs Dezso, Balazs I Toth, et al.
Epidemiology and Infection|July 23, 2013
Use of virulence determinants and seropathotypes to distinguish high- and low-risk Escherichia coli O157 and non-O157 isolates from EuropeM F Anjum, E Jones, V Morrison, et al.
Molecular Cancer Therapeutics|July 5, 2024
Discovery of Monovalent Direct Degraders of BRD4 that Act via the Recruitment of DCAF11Gregory S Parker, Julia I Toth, Sarah Fish, et al.
Molecular Cancer Therapeutics|June 22, 2024
Discovery of Monovalent Direct Degraders of BRD4 That Act Via the Recruitment of DCAF11Gregory S Parker, Julia I Toth, Sarah Fish, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery and Structural Optimization of BRD4-Selective Monovalent Direct DegradersGeoffray Leriche, Farhana Barmare, Julia I Toth, et al.
Plos One|April 3, 2014
Mutations in UBA3 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cellsG Wei Xu, Julia I Toth, Sara R da Silva, et al.
Science (New York, N.Y.)|May 19, 2001
HST and VLT investigations of the fragments of comet C/1999 S4 (LINEAR)H A Weaver, Z Sekanina, I Toth, et al.
Pageof 11